Page last updated: 2024-09-04

ivabradine and aliskiren

ivabradine has been researched along with aliskiren in 2 studies

Compound Research Comparison

Studies (ivabradine)	Trials (ivabradine)	Recent Studies (post-2010) (ivabradine)	Studies (aliskiren)	Trials (aliskiren)	Recent Studies (post-2010) (aliskiren)
1,143	197	833	978	211	611

Protein Interaction Comparison

Protein	Taxonomy	aliskiren (IC50)
Renin	Homo sapiens (human)	0.001
Renin-1	Mus musculus (house mouse)	0.0045
Renin	Rattus norvegicus (Norway rat)	0.084
Cytochrome P450 3A4	Homo sapiens (human)	0.0004
Cytochrome P450 2C9	Homo sapiens (human)	0.0023
Renin	Macaca mulatta (Rhesus monkey)	0.0012
Renin	Oryctolagus cuniculus (rabbit)	0.011

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dei Cas, L; Lupi, L; Manerba, A; Nodari, S; Triggiani, M	1
Adhyaru, B; Raj, L	1

Reviews

1 review(s) available for ivabradine and aliskiren

Article	Year
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF). Postgraduate medical journal, 2016, Volume: 92, Issue:1094 Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents	2016

Article

Year

An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).

Postgraduate medical journal, 2016, Volume: 92, Issue:1094

Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents

2016

Other Studies

1 other study(ies) available for ivabradine and aliskiren

Article	Year
[Chronic heart failure therapy: where we are and where we are going to]. Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:10 Suppl 2 Topics: Algorithms; Amides; Benzazepines; Chronic Disease; Fumarates; Heart Failure; Heart Rate; Humans; Ivabradine	2012